Unknown

Dataset Information

0

Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells.


ABSTRACT: Signal abnormalities in human cells usually cause unexpected consequences for individual health. We focus on these kinds of events involved in JAK-STAT signal pathways, especially the ones triggered by aberrant activated STAT3, an oncoprotein which participates in essential processes of cell survival, growth and proliferation in many types of tumors, as well as immune diseases. By establishing a STAT3 signal based high-throughput drug screening system in human lung cancer A549 cells, we have screened a library from natural products which contained purified compounds from medicinal herbs. One compound, named Brevilin A, exhibited both strong STAT3 signal inhibition and STAT3 signal dependent cell growth inhibition. Further investigations revealed that Brevilin A not only inhibits STAT3 signaling but also STAT1 signaling for cytokines induced phosphorylation of STAT3 and STAT1 as well as the expression of their target genes. In addition, we found Brevilin A could attenuate the JAKs activity by blocking the JAKs tyrosine kinase domain JH1. The levels of cytokine induced phosphorylation of STATs and other substrates were dramatically reduced by treatment of Brevilin A. The roles of Brevilin A targeting on JAKs activity indicate that Brevilin A may not only be used as a STAT3 inhibitor but also a compound blocking other JAK-STAT hyperactivation. Thus, these findings provided a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs.

SUBMITTER: Chen X 

PROVIDER: S-EPMC3660600 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells.

Chen Xing X   Du Yuping Y   Nan Jing J   Zhang Xinxin X   Qin Xiaodong X   Wang Yuxin Y   Hou Jianwen J   Wang Qin Q   Yang Jinbo J  

PloS one 20130521 5


Signal abnormalities in human cells usually cause unexpected consequences for individual health. We focus on these kinds of events involved in JAK-STAT signal pathways, especially the ones triggered by aberrant activated STAT3, an oncoprotein which participates in essential processes of cell survival, growth and proliferation in many types of tumors, as well as immune diseases. By establishing a STAT3 signal based high-throughput drug screening system in human lung cancer A549 cells, we have scr  ...[more]

Similar Datasets

| S-EPMC6100543 | biostudies-literature
| S-EPMC5133974 | biostudies-literature
| S-EPMC7315608 | biostudies-literature
| S-EPMC6796319 | biostudies-literature
| S-EPMC8533975 | biostudies-literature
| S-EPMC5833361 | biostudies-literature
| S-EPMC5190071 | biostudies-literature
| S-EPMC10977912 | biostudies-literature
| S-EPMC6697619 | biostudies-literature
| S-EPMC3968804 | biostudies-literature